Literature DB >> 20932740

Breast cancer in pregnancy: recommendations of an international consensus meeting.

Frédéric Amant1, Sarah Deckers, Kristel Van Calsteren, Sibylle Loibl, Michael Halaska, Lieselot Brepoels, Jos Beijnen, Fatima Cardoso, Oreste Gentilini, Lieven Lagae, Olivier Mir, Patrick Neven, Nelleke Ottevanger, Steven Pans, Fedro Peccatori, Roman Rouzier, Hans-Jörg Senn, Henk Struikmans, Marie-Rose Christiaens, David Cameron, Andreas Du Bois.   

Abstract

PURPOSE: To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy.
METHODS: An international expert Panel convened to address a series of questions identified by a literature review and personal experience. Issues relating to the diagnosis and management of breast cancer after delivery were outside the scope.
RESULTS: There is a paucity of large and/or randomized studies. Based on cohort studies, case series and case reports, the recommendations represent the best available evidence, albeit of a lower grade than is optimal. RECOMMENDATIONS: In most circumstances, serious consideration should be given to the option of treating breast cancer whilst continuing with the pregnancy. Each woman should ideally be referred to a centre with sufficient expertise, given a clear explanation of treatment options. Most diagnostic and staging examinations can be performed adequately and safely during pregnancy. Treatment should however be adapted to the clinical presentation and the trimester of the pregnancy: surgery can be performed during all trimesters of pregnancy; radiotherapy can be considered during the first and second trimester but should be postponed during the third trimester; and standard chemotherapies can be used during the second and third trimester. Since neonatal morbidity mainly appears to be related to prematurity, delivery should not be induced before 37 weeks, if at all possible.
CONCLUSIONS: The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932740     DOI: 10.1016/j.ejca.2010.09.010

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  48 in total

1.  Challenges in managing breast cancer during pregnancy.

Authors:  Flora Zagouri; Theodora Psaltopoulou; Constantine Dimitrakakis; Rupert Bartsch; Meletios-Athanassios Dimopoulos
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Misconceptions surrounding pregnancy-associated breast cancer.

Authors:  Nada Khalil; Clare Fowler
Journal:  BMJ Case Rep       Date:  2018-12-17

3.  Being Pregnant and Diagnosed with Breast Cancer.

Authors:  Sibylle Loibl; Sileny N Han; Frederic Amant
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

4.  The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).

Authors:  Haiyan Hu; Shuqin Li; Xiuying Cui; Xiaobin Lv; Yu Jiao; Fengyan Yu; Herui Yao; Erwei Song; Yongsong Chen; Minghui Wang; Ling Lin
Journal:  J Biol Chem       Date:  2013-02-22       Impact factor: 5.157

5.  Pregnancy-associated breast cancer: clinicopathological characteristics of 20 cases with a focus on identifiable causes of diagnostic delay.

Authors:  Derman Basaran; Mert Turgal; Kemal Beksac; Ozgur Ozyuncu; Omer Aran; M Sinan Beksac
Journal:  Breast Care (Basel)       Date:  2014-10       Impact factor: 2.860

6.  Breast Cancer during Pregnancy: An Interdisciplinary Approach in Our Institution.

Authors:  Cristina Pirvulescu; Christine Mau; Holger Schultz; Antje Sperfeld; Annette Isbruch; Heike Renner-Lützkendorf; Sybille Loibl; Ulrike Freitag; Gabriele Klühs; Barbara Fleige; Michael Untch
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

Review 7.  Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons.

Authors:  Pavol Zubor; Peter Kubatka; Ivana Kapustova; Lence Miloseva; Zuzana Dankova; Alexandra Gondova; Tibor Bielik; Stefan Krivus; Jan Bujnak; Zuzana Laucekova; Christina Kehrer; Erik Kudela; Jan Danko
Journal:  EPMA J       Date:  2018-06-24       Impact factor: 6.543

8.  Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study.

Authors:  Lisa Prior; Richard O'Dwyer; Abdul Rehman Farooq; Megan Greally; Cian Ward; Connor O'Leary; Razia Aslam; Waseem Darwish; Nada Ahmed; Elly Che Othman; Geoffrey Watson; Deirdre Kelly; Jack Gleeson; Lisa Kiely; Anees Hassan; Elaine M Walsh; David O'Reilly; Alfred Jones; Hannah Featherstone; Marvin Lim; Hazel Murray; Bryan T Hennessy; Lillian M Smyth; Gregory Leonard; Liam Grogan; Oscar Breathnach; Paula Calvert; Anne M Horgan; Linda Coate; Emmet J Jordan; Deirdre O'Mahony; Rajnish Gupta; Maccon M Keane; Jennifer Westrup; Karen Duffy; Miriam O'Connor; Patrick G Morris; M John Kennedy; Seamus O'Reilly; John McCaffrey; Catherine M Kelly; Desmond Carney; Giuseppe Gullo; John Crown; Michaela J Higgins; Paul M Walsh; Janice M Walshe
Journal:  Breast Cancer Res Treat       Date:  2021-06-14       Impact factor: 4.872

9.  Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.

Authors:  Nikita M Shah; Dana M Scott; Pridvi Kandagatla; Molly B Moravek; Erin F Cobain; Monika L Burness; Jacqueline S Jeruss
Journal:  Ann Surg Oncol       Date:  2019-01-24       Impact factor: 5.344

Review 10.  Pregnancy associated breast cancer and pregnancy after breast cancer treatment.

Authors:  Emek Doğer; Eray Calışkan; Peter Mallmann
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.